2-24017520-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001346880.2(MFSD2B):c.613G>A(p.Gly205Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,584,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001346880.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MFSD2B | NM_001346880.2 | c.613G>A | p.Gly205Ser | missense_variant | 6/14 | ENST00000338315.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MFSD2B | ENST00000338315.6 | c.613G>A | p.Gly205Ser | missense_variant | 6/14 | 5 | NM_001346880.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152084Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000555 AC: 11AN: 198156Hom.: 0 AF XY: 0.0000654 AC XY: 7AN XY: 106980
GnomAD4 exome AF: 0.000110 AC: 158AN: 1431852Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 76AN XY: 709402
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2023 | The c.613G>A (p.G205S) alteration is located in exon 6 (coding exon 6) of the MFSD2B gene. This alteration results from a G to A substitution at nucleotide position 613, causing the glycine (G) at amino acid position 205 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at